首页|CT平扫联合增强及门静脉系统重建对于肝硬化门静脉系统血栓患者的影像价值评估分析

CT平扫联合增强及门静脉系统重建对于肝硬化门静脉系统血栓患者的影像价值评估分析

Evaluation of CT plain scan combined with enhancement and portal vein system reconstruction in patients with portal vein thrombosis in cirrhosis

扫码查看
目的 对CT平扫联合增强及门静脉系统重建对于肝硬化门静脉系统血栓患者的影像价值进行评估分析.方法 选取2019年1月~2022年9月期间本院收治的肝硬化患者,选取合并门静脉系统血栓患者35例作为实验组,未合并门静脉系统血栓患者35例为对照组,作为本次研究的主要研究对象,对其进行CT平扫联合增强及门静脉系统重建分析,对其诊断效能进行分析.结果 实验组门静脉系统血栓5例(14.29%)仅累及门静脉主干,7例(20.00%)仅累及肠系膜上静脉,累及门静脉及脾静脉6例(17.14%),同时累及肠系膜上静脉及脾静脉7例(20.00%),10例(28.57%)同时累及门静脉、肠系膜上静脉及脾静脉,对照组无门静脉血栓;实验组Ⅲ型前胶原N端肽N-P Ⅲ(58.26±5.26)ng/mL,Ⅳ型胶原CIV(96.29±5.76)ng/mL,层粘连蛋白CNLDB(76.26±6.59)ng/mL,透明质酸HA(86.65±9.65)ng/mL;对照组Ⅲ型前胶原N端肽N-P Ⅲ(32.61±4.25)ng/mL,Ⅳ型胶原CIV(48.11±5.14)ng/mL,层粘连蛋白CNLDB(41.56±4.98)ng/mL,透明质酸HA(45.89±5.69)ng/mL,各项指标差异均有统计学意义(P < 0.05).结论 对于疑似肝硬化门静脉系统的患者采用CT平扫联合增强及门静脉系统重建,能有效确诊患者是否门静脉血栓,且操作简单便捷,整个过程为无创,更容易被广大患者接受,成像质量高.
Objective To evaluate the imaging value of CT plain scan combined with enhancement and portal vein reconstruction in patients with portal vein thrombosis in cirrhosis. Methods The patients with cirrhosis admitted to our hospital from January 2019 to September 2022 were selected, 35 patients with portal vein thrombosis were selected as the experimental group, and 35 patients without portal vein thrombosis were selected as the control group. As the main research objects of this study, CT plain scan combined with enhancement and portal vein system reconstruction were analyzed. The diagnostic efficiency was analyzed. Results In the experimental group, portal vein thrombosis only involved the main portal vein in 5 cases (14.29%), superior mesenteric vein in 7 cases (20.00%), portal vein and splenic vein in 6 cases (17.14%), and superior mesenteric vein and splenic vein in 7 cases (20.00%). In 10 cases (28.57%), portal vein, superior mesenteric vein and splenic vein were involved, and no portal vein thrombosis was found in the control group. In the experimental group, type Ⅲ procollagen n-terminal peptide N-PⅢ (58.26±5.26) ng/mL, type Ⅳ collagen CIV (96.29±5.76) ng/mL, laminin CNLDB (76.26±6.59) ng/mL, hyaluronic acid HA (86.65±9.65) ng/mL; In control group, type Ⅲ procollagen n-terminal peptide N-PⅢ (32.61±4.25) ng/mL, type Ⅳ collagen CIV (48.11±5.14) ng/mL, laminin CNLDB (41.56±4.98) ng/mL, hyaluronic acid HA (45.89±5.69) ng/mL, The differences of all indexes were statistically significant (P<0.05). Conclusion For patients with suspected cirrhosis of the portal vein system, CT plain scan combined with enhancement and reconstruction of the portal vein system can effectively confirm whether the patient has portal vein thrombosis, and the operation is simple and convenient. The whole process is non-invasive, more easily accepted by the majority of patients, and the imaging quality is high.

CT plain scan combined with enhancementportal vein system reconstructionportal vein thrombosis in cirrhosisimage value evaluation

李洋、Tong Peng-fei、高茜、Chen Xu-lei

展开 >

无锡市第二人民医院,影像科,江苏 无锡 214000

Department of Imaging, The Second People's Hospital of Wuxi, Wuxi 214000, China

Department of Pathology, The Second People's Hospital of Wuxi, Wuxi 214000, China

CT平扫联合增强 门静脉系统重建 肝硬化门静脉系统血栓 影像价值评估

2023

科学养生
中国医院管理杂志社

科学养生

影响因子:0.019
ISSN:1672-9714
年,卷(期):2023.26(1)
  • 11